Goldman Sachs’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537K | Buy |
353,307
+22,766
| +7% | +$34.6K | ﹤0.01% | 4222 |
|
|
2025
Q1 | $458K | Sell |
330,541
-180,974
| -35% | -$251K | ﹤0.01% | 4305 |
|
|
2024
Q4 | $1.16M | Buy |
511,515
+190,156
| +59% | +$432K | ﹤0.01% | 3817 |
|
|
2024
Q3 | $1.52M | Sell |
321,359
-74,464
| -19% | -$351K | ﹤0.01% | 3541 |
|
|
2024
Q2 | $2.96M | Sell |
395,823
-29,351
| -7% | -$220K | ﹤0.01% | 2965 |
|
|
2024
Q1 | $7.25M | Buy |
425,174
+187,037
| +79% | +$3.19M | ﹤0.01% | 2299 |
|
|
2023
Q4 | $5.41M | Sell |
238,137
-61,915
| -21% | -$1.41M | ﹤0.01% | 2536 |
|
|
2023
Q3 | $4.57M | Buy |
+300,052
| New | +$4.57M | ﹤0.01% | 2538 |
|
|
2023
Q2 | – | Sell |
-161,596
| Closed | -$1.34M | – | 4957 |
|
|
2023
Q1 | $1.34M | Buy |
+161,596
| New | +$1.34M | ﹤0.01% | 3480 |
|
|
2022
Q4 | – | Sell |
-10,996
| Closed | -$7K | – | 5166 |
|
|
2022
Q3 | $7K | Sell |
10,996
-2,949
| -21% | -$1.88K | ﹤0.01% | 5289 |
|
|
2022
Q2 | $15K | Buy |
13,945
+86
| +0.6% | +$93 | ﹤0.01% | 5466 |
|
|
2022
Q1 | $28K | Buy |
13,859
+685
| +5% | +$1.38K | ﹤0.01% | 5564 |
|
|
2021
Q4 | $50K | Sell |
13,174
-29,793
| -69% | -$113K | ﹤0.01% | 5355 |
|
|
2021
Q3 | $522K | Buy |
42,967
+7,594
| +21% | +$92.3K | ﹤0.01% | 4356 |
|
|
2021
Q2 | $304K | Sell |
35,373
-9,514
| -21% | -$81.8K | ﹤0.01% | 4699 |
|
|
2021
Q1 | $498K | Buy |
44,887
+13,407
| +43% | +$149K | ﹤0.01% | 4362 |
|
|
2020
Q4 | $393K | Buy |
31,480
+6,411
| +26% | +$80K | ﹤0.01% | 3955 |
|
|
2020
Q3 | $272K | Sell |
25,069
-3,531
| -12% | -$38.3K | ﹤0.01% | 3942 |
|
|
2020
Q2 | $319K | Buy |
28,600
+3,297
| +13% | +$36.8K | ﹤0.01% | 3795 |
|
|
2020
Q1 | $185K | Buy |
+25,303
| New | +$185K | ﹤0.01% | 3966 |
|